RECENT POSTS
- Your First Move For Monday November 16th
- Web Extra: Where Will The Next Bull Come From?
- Burned by Yahoo!, Disney and More
- The Latest Picks That Paid – Friday November 13th
- Pops & Drops: Dow Chemical, Macy's...
- Chartology – Can Stocks Break Above 1100?
- Fast Action: Using Options To Play Housing Bottom
- Bold Call Of The Day – Microsoft
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
The health care sector today just went positive for 2009, making it the only major industry group to currently be in the green for this young year. The Health Care Select Sector SPDR ETF [XLV
Loading...
()
] is higher today on the back of better-than-expected results from Merck [MRK
Loading...
()
] and Schering-Plough [SGP
Loading...
()
]. Credit ok earnings, buyout activity (Pfizer target Wyeth is the sector's top performer) and investors crowding into a defensive sector to heal their portfolio's wounds for 2009's outperformance.
But will this sector's good fortune last? Brown Brothers Harriman's Andrew Burkly, a technical analyst and frequent Fast Money guest, thinks so. The sector has momentum and strong support at its 50-day moving average, a common metric used by chart-watchers.
 |
"We continue to like the S&P 500 Health Care Sector based on its technical profile and defensive characteristics," writes Burkly, in a note to clients this morning.
An even better way to play the trends unfolding in the space is to bet on biotech directly, according to FM traders Pete Najarian and Karen Finerman. They've been recommending the Biotech SPDR ETF [XBI
Loading...
()
], with top holdings like Amgen [AMGN
Loading...
()
] and Genentech [DNA
Loading...
()
]. Genentech got some positive news today related to its Avastin lung cancer drug.
John Melloy is the Senior Editorial Producer for Fast Money. Before joining CNBC, he was an editor for Bloomberg News, overseeing the U.S. Stock Market coverage team.______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! If you'd prefer to make a comment but not have it published on our website send your message to .
Data is a real-time snapshot *Data is delayed at least 15 minutes